The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Journal:
PLoS Med
13(2):e1001955
Publish Date:
2016-02-01
Author Profiles:
Caring for 'Very Important Patients'--Ethical Dilemmas and Suggestions for Practical Management.
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Journal:
PLoS Med
13(2):e1001955
Publish Date:
2016-02-01
Author Profiles:
In Favour of Medical Dissensus: Why We Should Agree to Disagree About End-of-Life Decisions.
Journal:
Bioethics
30(2):109-18
Publish Date:
2016-02-01
Author Profiles:
Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature.
Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies.
Journal:
Health Aff (Millwood)
35(2):219-26
Publish Date:
2016-02-01
Author Profiles:
Measuring and Improving, Not Just Describing-The Next Imperative for End-of-Life Care.
Journal:
Pediatr Crit Care Med
17(2):167-8
Publish Date:
2016-02-01
Author Profiles:
Medically Inappropriate or Futile Treatment: Deliberation and Justification.
Journal:
J Med Philos
41(1):90-114
Publish Date:
2016-02-01
Author Profiles:
Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
Insulin patents and market exclusivities: unresolved issues--Authors' reply.
Journal:
Lancet Diabetes Endocrinol
4(2):98-9
Publish Date:
2016-02-01
Author Profiles: